This is why weight-loss GLP-1 medications have become so widely discussed in recent years
All GLP-1 receptor agonists are safe in terms of cardiovascular outcomes, and liraglutide, semaglutide, albiglutide, dulaglutide and efpeglenatide have been shown to have cardiovascular benefits in cardiovascular outcomes trials [22]
10.1079/bjn19920054 Br J Nutr
You dont know whats in the formulation
Etiopathogenesis of cataract: An appraisal
compared to the WKY group, glycerylphosphorylcholine, LysoPC (18:0/0:0), PC (18:0/22:6 (4Z,7Z,10Z,13Z,16Z,19Z)), and PS (20:4 (8Z,11Z,14Z,17Z)/22:2 (13Z,16Z)) were expressed at higher levels in the ESC group, while the remaining 11 differential metabolites were downregulated